The global autoinjectors market is projected to reach USD 104.9 billion by 2025 from USD 46.0 billion in 2020, at a CAGR of 17.9% from 2020 to 2025. Market growth is largely driven by the growing prevalence of targeted therapies, the rising incidence of anaphylaxis, rising preference for self-administration of drugs, usability advantages, the increasing number of regulatory approvals, the availability of generic versions of autoinjectors, favorable reimbursements and government support, and technological advancements. The patent expiry of biologics is also expected to provide growth opportunities for players in the market. On the other hand, the preference for alternative routes of drug delivery such as oral diabetic agents and nasal epinephrine sprays is expected to limit the adoption of autoinjector devices.
The rheumatoid arthritis segment accounted for the largest share of the autoinjectors market in 2020 Based on therapy, the autoinjectors market is segmented into rheumatoid arthritis, multiple sclerosis, anaphylaxis, diabetes, and other therapies (cardiovascular diseases, migraine treatment, anemia, and progesterone therapy).In 2019, rheumatoid arthritis accounted for the largest market share of autoinjectors market.
The large share of this segment is mainly due to the high prevalence of rheumatoid arthritis.
The subcutaneous segment is projected to grow at the highest CAGR during the forecast period Based on route of administration, the autoinjectors market is segmented into intramuscular and subcutaneous.Patients use autoinjectors for intramuscular and subcutaneous administration of various drugs for the treatment of diseases such as rheumatoid arthritis, multiple sclerosis, anaphylaxis, diabetes, migraine, anemia, and cancer.
The subcutaneous segment is projected to grow at the highest CAGR during the forecast period. The highest CAGR of this segment can primarily be attributed to the growing number of product approvals by regulatory bodies for the treatment of chronic diseases.
North America accounted for the largest share of the autoinjectors market in 2020. The autoinjectors market is segmented into five major regions, namely, Europe, North America, the Asia Pacific, Latin America, and the Middle East & Africa.North America was the largest regional market for autoinjectors.
Growth in the North American market is majorly driven by factors such as the rising incidence of anaphylaxis and the presence of favorable reimbursements.Moreover, the US and Canada are developed economies with high awareness and adoption rates for advanced devices such as autoinjectors, which is beneficial for market growth.
Furthermore, other microeconomic indicators such as rising healthcare expenditures, high affordability rate, and the improving regulatory scenario are also major factors contributing to market growth. • By Company: Tier 1: 40%, Tier 2: 35%, and Tier 3: 25% • By Designation: C-level Executives: 25%, Directors: 55%, and Others: 20% • By Region: North America: 40%, Europe: 25%, APAC: 20%, LATAM: 10% and MEA: 5%
Some of the key players in the autoinjectors market are AbbVie Inc. (US), Mylan (US), Eli Lilly and Company (US), Ypsomed (Switzerland), Amgen (US), Becton, Dickinson and Company (US), GlaxoSmithKline plc (UK), Johnson & Johnson (US), Teva Pharmaceutical (Israel), Antares Pharma (US), Merck KGaA (Germany), Meridian Medical Technologies, Inc. (US), Roche Diagnostics (Switzerland), Bespak (UK), Bayer (Germany), SHL Medical (Switzerland), Haselmeier (Switzerland), Owen Mumford (UK), Ravimed (Poland), Medeca Pharma AB (Sweden), Cambridge Consultants Ltd. (UK), Flex (US), SMC Ltd. (US), and Promius Pharma (US). The study includes an in-depth competitive analysis of these key players in the autoinjectors market, along with their company profiles, recent developments, and key market strategies.
Research Coverage: The market study covers the autoinjectors market across various segments.It aims at estimating the market size and the growth potential of this market across different segments by therapy, type, route of administration, end users and region.
The study also includes an in-depth competitive analysis of the key players in the market, along with their company profiles, key observations related to their product and business offerings, recent developments, and key market strategies.
Key Benefits of Buying the Report: The report will help market leaders/new entrants in this market and provide information regarding the closest approximations of the autoinjectors market and its subsegments.This report will help stakeholders understand the competitive landscape, gain insights to position their businesses better, and plan suitable go-to-market strategies.
The report will also help stakeholders understand the pulse of the market and provide information on key market drivers, restraints, opportunities and challenges.
Our reports have been used by over 10K customers, including:
The major factors attributing to the growth of the biosurgery market are increasing geriatric population, rising prevalence of chronic diseases and related surgeries, and a strong focus on R&D leading to the launch of new and advanced products. The global increase in the number of geriatrics population and obese people is likely to...
Certain factors that are driving the market growth include rising healthcare expenditure, growing burden of chronic diseases and advances in drug discovery and development. The burden of chronic diseases is increasing worldwide. According to WHO, chronic diseases have always been a massive global challenge, and they account for approximately...
The late stage chronic kidney disease drugs market was valued at US$ 4,680.0 million in 2019 and is projected to reach US$ 11,096.9 million by 2027; it is expected to grow at a CAGR of 11.6% during 2020–2027. The growth of the late stage chronic kidney disease drugs market is mainly attributed to the factors such as high prevalence...
The Nitinol Medical Devices Market is expected to register a CAGR of 9.1% over the forecast period. Growing burden of diseases and increasing adoption of minimally invasive surgeries is expected to propel the global nitinol medical devices market growth. Nitinol known for its super-elasticity, has wide number of applications in the healthcare...
Global centesis catheters market is projected to grow at a CAGR of 6.8% The global centesis catheters market is projected to reach USD 633 million by 2025 from USD 426 million in 2019, growing at a CAGR of 6.8% from 2019 to 2025. The key factors driving the growth of this market include the rising target patient population...
Global Surface Disinfectant market is expected to witness a CAGR of 9.95% during the forecast period. Certain factors that are driving the market growth include rising incidence of hospital-acquired infections, growing geriatric population and subsequent growth in the prevalence of chronic diseases, and the increasing number of surgical procedures. Due...
Biochips are being increasingly used in the area of biomedical and biotechnological research. With the advancement of technology in the medical field, there has been a rise in adoption of biochips in proteomics, such as in microarrays. The advantages of protein biochips include low sample consumption and its inclination towards miniaturization....
The market for advanced medical stopcock in the Asia Pacific is expected to reach US$ 201.5 Mn in 2027 from US$ 137.9 Mn in 2018. The growth rate of the market in the region is estimated to be 4.5% during the forecast period. The growth of the market is majorly contributed by the rising prevalence of the infectious disease across the region...
The oxidative stress assay market is projected to reach USD 1,326 million by 2025 from USD 836 million in 2020, at a CAGR of 9.7%. Growth in the oxidative stress assay market can be attributed to growth in the biopharmaceutical industry and increasing public-sector funding for academic research. Other important factors aiding the growth of...
70 pages •
By Infiniti Research Limited
• Mar 2017
OCT can help to identify diseases such as diabetic retinopathy and glaucoma at the granular level by providing the images of the retina in layers, which can help physicians identify the disease and form a treatment plan.
Technavio’s analysts forecast the global OCT market to grow at a CAGR of 8.16% during...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.